aTyr Pharma Inc.

NASDAQ: LIFE · Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM

aTyr Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.05M 22.54M 9.98M 2.34M
Short-Term Investments
n/a 75.62M 56.16M 105.58M
Long-Term Investments
n/a 3.48M 3.17M n/a
Other Long-Term Assets
3.02M 3.62M -22K n/a
Receivables
1.74M 2.44M 11.78M 435K
Inventory
n/a n/a -2.95M n/a
Other Current Assets
69.16M 2.39M 2.95M 5.38M
Total Current Assets
81.95M 102.99M 81.09M 113.73M
Property-Plant & Equipment
11.86M 14.05M 11.56M 1.81M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
14.88M 17.66M 14.7M 1.81M
Total Assets
96.83M 120.65M 95.79M 115.54M
Account Payables
4.32M 3.53M 3.11M 1.03M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.25M 1.33M 894K 980K
Other Current Liabilities
9.39M 11.56M 9.86M 4M
Total Current Liabilities
14.97M 16.42M 13.86M 6.01M
Long-Term Debt
12.03M 13.77M 10.64M 398K
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
12.03M 15.18M 10.64M 398K
Total Liabilities
26.81M 31.6M 24.5M 6.41M
Total Debt
13.28M 15.1M 11.53M 1.38M
Common Stock
84K 63K 29K 28K
Retained Earnings
-532.05M -468.02M -417.63M -372.3M
Comprehensive Income
-40K -74K -433K -263K
Shareholders Equity
70.02M 90.66M 71.28M 109.13M
Total Investments
n/a 79.11M 56.16M 105.58M